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Abstract
Disease-causing mutations usually change the interacting partners of mutant proteins. In
this article, we propose that the biological consequences of mutation are directly related
to the alteration of corresponding protein protein interaction networks (PPIN). Mutation
of Huntingtin (HTT) which causes Huntington’s disease (HD) and mutations to TP53
which is associated with different cancers are studied as two example cases. We construct
the PPIN of wild type and mutant proteins separately and identify the structural modules
of each of the networks. The functional role of these modules are then assessed by Gene
Ontology (GO) enrichment analysis for biological processes (BPs). We find that a large
number of significantly enriched (p < 0.0001) GO terms in mutant PPIN were absent in
the wild type PPIN indicating the gain of BPs due to mutation. Similarly some of the
GO terms enriched in wild type PPIN cease to exist in the modules of mutant PPIN,
representing the loss. GO terms common in modules of mutant and wild type networks
indicate both loss and gain of BPs. We further assign relevant biological function(s) to
each module by classifying the enriched GO terms associated with it. It turns out that
most of these biological functions in HTT networks are already known to be altered in
HD and those of TP53 networks are altered in cancers. We argue that gain of BPs, and
the corresponding biological functions, are due to new interacting partners acquired by
mutant proteins. The methodology we adopt here could be applied to genetic diseases
where mutations alter the ability of the protein to interact with other proteins.
Introduction
Cellular functions are carried out by proteins interacting with other proteins and macro-
molecules like DNA, RNA, etc. It is believed [1] that the modular organization of cellular
functions are related to the underlying modular structure of the protein protein interac-
tion network (PPIN). Understanding PPIN would elucidate how such interactions execute
2basic functions in cells and may explain the abnormalities arising from mutations in genes.
In particular, mutation at the binding site of a protein may lead to loss of it’s ability to
function together with existing interacting partner(s). On the other hand, mutation may
also create regions where new protein partners can bind. Therefore, loss or gain of interac-
tion due to mutation may contribute to causation, progression or modulation of disease.
It has been reported recently [2] that out of 119 mutations in 65 distinct diseases, 95
mutations result in loss of function (LOF), 17 mutations result in gain of function (GOF)
and 4 mutations changes the preferences for interaction. Based on this experimentally
validated data, it has been predicted that 1428 mutations might be related to interaction
defect. Using the structural information at atomic levels either through crystallography
or homology modeling, it has been shown that 21, 716 mutations in 624 genes either alter
amino acid sequences or produce truncated proteins. Among 12, 059 mutations that alter
amino acid sequences, 7833 mutations are located in the interface of interaction with other
proteins. Such mutations at interfaces of interactions may disrupt or enhance the interac-
tions with the partners. This study also emphasizes the role of loss or gain of interactions
of mutant proteins in human diseases. However, for such analysis, it is necessary to have
structural information at atomic levels, which may be achieved if 3-dimensional structures
of the proteins or their homologs are known. But, for the most of the protein protein
interactions such information is not available [3]. Moreover, very little is known about
the role of such altered interactions in corresponding pathological conditions. It remains
a challenge to relate genetic mutation data to PPIN and to understand molecular cause
of disease. In the present communication, we probe whether gain or loss of interactions
of mutant Huntingtin protein (HTT) that causes Huntingtons disease (HD) can explain
functional abnormalities observed in HD. We have also used the same approach to find
how loss or gain of interactions of mutant TP53 in cancers may result in alterations of
functions.
Analysis and Results
Mutation in HTT protein
Huntingtons disease (OMIM ID: 143100) is a rare autosomal dominant progressive degen-
erative neurological disease caused by expansion of normally polymorphic CAG repeats
beyond 36 at the exon1 of the gene Huntingtin (HTT) [4]. Over the years, various cel-
lular processes/conditions like excitotoxicity, oxidative stress, mitochondrial dysfunction,
endoplasmic reticulum stress, axonal transport, ubiquitin proteasome system, autophagy,
transcriptional deregulation and apoptosis have been implicated in HD pathology [5, 6].
Even though GOF was inferred initially from the autosomal dominant nature of trans-
mittance of the disease, the underlying molecular details still remain largely unknown.
Inverse correlations between age at onset and number of CAG repeat beyond 36 in HTT
gene, increased aggregates of mutant HTT (mHTT) and apoptosis, correlation of CAG
3repeat numbers in HTT gene with levels of ATP/ADP and altered expression of few
genes [4,7–10] suggest toxic GOF of mutant protein that disrupts normal cellular functions
and causes neuronal death. Mutant HTT preferentially interacts with DNA sequences, al-
ters conformation of DNA facilitating binding of other transcription factors to the specific
sequences and modulates transcription of genes. This result also indicates a dominant
GOF of mHTT [11]. Wild type HTT (wHTT) is known to be involved in protection of
apoptosis [12–15], regulation of gene expression [16, 17], mitosis and neurogenesis [18],
neuronal development [19] and maintenance of body weight [20]; all these processes are
altered in HD [5,6]. These results indicate that loss of one of the alleles in HD could con-
tribute to increased apoptosis and altered gene expressions observed in HD. LOF of wild
type protein may thus contribute, at least partially, to HD pathology [21]. There are also
several experimental evidences available against simple LOF(s) of wild type HTT [22–25].
Construction of HTT-interacting protein network
We have collected the HTT interacting proteins from published data and find that 17
proteins preferentially interact with wHTT, while 37 proteins are either identified in ag-
gregates of mHTT only or interact preferentially with mHTT (the references for each of
the observations are provided in Dataset S1 (sheet 1) and in Supporting Text (Text 1)).
These 17 and 37 proteins are referred to as the primary interactors of wHTT and mHTT
respectively. Next, we assimilate interacting partners of these primary interactors from
BioGrid (Version 3.1.88, May 2012), a public database that contains genetic and protein
protein interaction data for humans and other organisms [26]. In the present study, we
have considered both physical and genetic interactions (refer to the section ‘Robustness
analysis’ for details). It turns out that there are 288 secondary interactors of wHTT (pro-
teins which interact with the 17 primary interactors), whereas there are 1504 secondary
proteins which interact with 37 primary interactors of mHTT. The PPIN of wHTT in-
teracting proteins is then constructed by considering all these 306 proteins (wHTT + 17
primary + 288 secondary interactors of wHTT) as nodes of the network; two nodes are
connected if corresponding pair of proteins are found to be interacting partners of each
other in BioGrid. Altogether there are 1397 interactions in wHTT network which are
listed in Dataset S1 (sheet 2). Similarly the PPIN of mHTT is constructed with 1542
nodes (mHTT + 37 primary + 1504 secondary interactors of mHTT) which has 13142
interactions from BioGrid (Dataset S1 (sheet 3)). We have used Cytoscape [27] for visual
presentation of the wHTT and mHTT networks, which are shown in Supporting Text
(Fig. S1). Both the networks are densely interconnected and the nodes are too tangled
there to find any apparent or obvious modular structures.
Characteristics of networks
A quantifiable description of these networks can be obtained by using graph theory, which
provides several measures for comparison and characterization of complex networks. The
4Figure 1. Construction and modularization of wild type and mutant HTT
networks.
(a) Proteins involved in the wHTT and mHTT networks: wHTT (mHTT) protein (red
square) has 17 (37) primary and 288 (1504) secondary interactors, shown schematically
as the inner and outer circles. Of the 17 primary interactors of wHTT, 8 proteins (deep
green) become secondary interactors of mHTT. Among the 288 secondary interactors of
wHTT, 107 (shaded) proteins remain as the secondary interactor of mHTT whereas 10
proteins (deep blue) becomes the primary interactors of mHTT. (b) and (c) Modules of
the wHTT and mHTT networks from NGM algorithm, which yields 7
(W1,W2, . . . ,W7) and 8 modules (M1,M2, . . . ,M8) respectively are shown along with
the relevant biological functions (obtained GO term enrichment analysis from
GeneCodis3). Significant functions associated with the modules are also shown. Details
of the GO terms are shown in Table S2 and Table S3 of the Supporting Text,
respectively for wHTT and mHTT.
most elementary characteristic of a node is its degree, k, which represents the number
of other nodes (proteins) it is connected with. The degree distribution, P (k), gives the
probability that a randomly selected node has exactly k links. We find that both the
wild and mutant PPINs follow a power law degree distribution, P (k) ∼ k−γ (Fig. S3
in Supporting Text) with exponents γ = 1.99, 1.95 and average degrees 〈k〉 = 9.13, 17.05
respectively. Another important quantity is the clustering coefficient which characterizes
how connected are the neighbors of a given node. It is observed that the average clustering
coefficient C = 0.361 for mHTT network is lower compared to C = 0.436 for wHTT PPIN.
This indicates that, the former network is less compact and the interacting partners of
the proteins are poorly connected among themselves. We have also calculated the average
shortest path length L, and the network diameter D (listed in Supporting Text (Table.
S2)), which describe the structural properties of the network. The detailed definitions of
C, D and L along with their evaluation procedure is illustrated in Supporting Text (Text
2).
5Gain and Loss of interactions due to mutation
A closer look at PPINs of wHTT and mHTT reveals that among the 17 primary interactors
of wHTT, 8 proteins still appear in PPIN of mHTT as secondary interactors, i.e. they
interact with some of the primary interactors of mHTT. Again, among 288 secondary
interactors of wHTT, 107 proteins are secondary interactors of mHTT, 10 proteins interact
directly with mHTT and the rest 171 proteins do not take part in PPIN of mHTT (see
Fig. 1(a)). Evidently, the mutant HTT network has gained several new interactions, 27
proteins as primary interactors and 1389 proteins as secondary interactors. This result
is shown schematically in Fig. 1(a) and the detailed list of these proteins is given in
Supporting Text (Text 1 and Table S1). Since mutation of HTT has changed the PPIN
substantially one expects a significant change in its functions.
Modules of wHTT and mHTT networks
There are several methods for obtaining natural modules of a network (or partitions of a
graph) [28]. We adopt Newman-Girvans modularization (NGM) algorithm [29], a com-
monly used method, to detect the modules of wHTT and mHTT networks. This algorithm
partitions the network in a way that the intra-module connections between nodes are max-
imized in comparison to the inter-module connections. To find the modules, Newman and
Girvan [30] proposed a score called modularity Q for every possible partition of a net-
work; the maximum value of Q corresponds to the best partition. The details of the NGM
algorithm for maximization of Q is described in Supporting Text (Text 2). The NGM
algorithm modularizes the PPIN of wHTT into 7 modules of sizes (18, 66, 79, 18, 82, 8
and 35) (see Table S2 in Supporting Text), with modularity Q = 0.415, whereas PPIN
of mHTT is partitioned into 8 modules of sizes (643, 3, 377, 2, 485, 7, 22 and 3) with
Q = 0.302. Modules of wHTT and mHTT networks are denoted by W and M respec-
tively. Figures 1(b) and (c) represent the modularized networks; all proteins belonging
to a given module are shown in same color. Clearly, the mHTT network is visibly more
complex than that of wHTT, which is consistent with the fact that it has a lower Q
value [31].
Similarity between the modules
Once the wild type and mutant networks are modularized, it is important to ask how
similar is a module of wild type network with that of mutant network, in terms of their
protein constituents. Mutant and wild type HTT networks have 125 proteins common
between them. After both the networks are modularized, these common proteins are
distributed among the pair of wHTT- mHTT modules. For example, the module M5
(485 proteins) has 49 proteins in common with W5 (485 proteins), whereas it has only
one common protein in W2 (out of 66 proteins) and two common proteins in W1 (18
6proteins). The detailed distribution of common proteins among wild and mutant modules
of HTT are shown in Fig. 2.
Figure 2. Similarity between modules of wHTT and mHTT networks. The
figure describes pictorially the closeness between the modules of wHTT and mHTT
PPIN; the modules having common protein or common GO terms are joined with edges
(numerical value written on the edge as : common proteins).
To calculate the similarity among modules, first we construct a unique set of proteins
from combining the proteins involved in the wild and mutant networks. This set consists
of 1723 proteins in case of HTT. Now every module of wHTT and mHTT are considered
as a unique 1723 dimensional vector as follows. Each protein is identified with a specific
position in the vector; presence (or absence) of a specific protein in a module, say w, is
mapped on to a corresponding vector ~Rw by inserting 1 (or 0) at respective position. A
similarity measure between a pair of modules w and m is well represented by the angle
θ(w,m) between the corresponding vectors ~Rw and ~Rm ,
θ(w,m) = cos−1
~Rw. ~Rm
|~Rw||~Rm|
It is rather simpler to use cos(θ(w,m)) as the similarity measure as cosine function is
monotonic in the range (0, π). It is easy to see that if the modules have Nw and Nm
proteins individually and Nwm protein in common, the similarity measure is
σ(w,m) ≡ cos(θ(w,m)) = Nwm/
√
NwNm. (1)
Clearly σ(w,m) varies in the range (0, 1) with maximum value 1 corresponding to the
fact that the modules are identical, i.e. they have same set of proteins.
In Fig. 2, we represent the similarity among modules of mHTT and wHTT as a
bipartite network with links having thickness proportional to σwm. The thickest link
between M5 andW5 indicates that these modules are significantly similar. For examples,
the module W5 has 82 proteins andM5 has 485 proteins; 49 proteins are common among
the proteins in these 2 modules; thus the protein similarity index for W5-M5 pair is
σ(W5,M5) = 0.246. Similarly among 66 proteins in W2 and 643 proteins in M1, 26
proteins are common (corresponding σ(W2,M1) = 0.126).
7Enrichment of GO terms for biological process
It has been observed that the proteins identified in a particular complex are involved
in similar functions [32]. From network perspective, these complexes are represented by
modules and they appear as distinct group of nodes which are highly interconnected with
each other but have only a few connections with the nodes outside of the module. It
is important to ask, if such a structural partition relates to any functional enrichment.
Among many bioinformatics tools available for such analysis [34] we utilize GeneCodis3
[33] (explained in Supporting Text (Text 3)) to obtain the possible Biological processes
enriched by the proteins in a given module. Given a query set of proteins GeneCodis3
provides the enriched biological process, molecular functions, and cellular components as
defined by the Gene ontology. Biological process in Gene ontology is described as a series
of events carried out by one or more ordered assemblies of molecular functions [35]. The
proteins in each module are used as input to GeneCodis3 [33] and significantly enriched
GO terms for BPs obtained using p-values calculated through Hypergeometric analysis
corrected for false discovery rate (FDR). Results of enrichment analyses for 7 modules of
wHTT and 8 modules of mHTT network are shown in Datasets S2 and S3 respectively.
Since many proteins are known to be involved in a particular BP, and a given protein
may also contribute to multiple BPs, it is likely that proteins in different modules in wHTT
and mHTT network participate in a specific BP due to either overlap in proteins or BPs.
To identify the overlaps of BPs between modules in wHTT and mHTT networks, we
separately identify the common GO terms between the wHTT and the mHTT modules.
It is evident from Dataset S4 (sheet 2) that 390 unique GO terms are being enriched
(p < 0.0001) due to proteins in modules of mHTT network, while 129 GO terms are
enriched with proteins in the modules of wHTT network (Dataset S2 (sheet 1)). Among
the GO terms present in wHTT and mHTT network, 65 are common. As a result due to
mutation, 325 GO terms are gained by mHTT and 64 GO terms are lost by wHTT. The
common 65 GO terms represents both gain and loss.
For convenience, we clubbed the the GO terms in a given module to broadly assign
one or more appropriate biological function(s). For example, GO:0010506 (regulation
of autophagy), GO:0016559 (peroxisome fission), GO:0031929 (TOR signaling cascade),
GO:0000045 (autophagic vacuole assembly), GO:0006897 (endocytosis) in module M1
are bought under a single biological function “Autophagy”. Similarly in module W4
GO:0043507 (positive regulation of JUN kinase activity), GO:0072383 (plus-end-directed
vesicle transport along microtubule), GO:0046330 (positive regulation of JNK cascade),
GO:0046328 (regulation of JNK cascade) are clubbed under “Signaling”. The assigned
biological functions for modules of wHTT and mHTT are shown in Fig. 1(b) and (c)
(details are given in Dataset S4).
Gain and loss of biological process in HTT networks
Comparison of enriched BPs in the modules of wHTT and mHTT reveal that the mHTT
8network has acquired several new BPs which were absent in wHTT, indicating gain of
biological processes. Similarly enriched BPs of wHTT which are not present in mHTT
are lost. Hence biological functions carried out by the BPs which are gained or lost in
mHTT networks may result in functional gain or loss due to mutation in HTT.
Gain of biological process : The unique GO terms enriched in the modules of mHTT
networks are listed in Dataset S4 (sheet 2) and in Supporting Text (Table S3). The GO
terms in module M1 are related to cell cycle (4 GO terms), signaling (30), transcription
processes and regulation (5), apoptosis (11), DNA damage and repair (6), Immunological
(7), protein folding (7), autophagy (5), translation (3), metabolism (1), development and
differentiation (4), cell migration and shape (4), proteasomal degradation (14), Protein
complex/membrane assembly/stabilization (9) and others (4). It is known that many of
these processes are involved in HD pathogenesis [36]. In M3, the enriched GO terms are
assigned to DNA repair (17), Transcription processes and regulation (5), DNA replication
(12), cell cycle (12) and others (5). Note that, it has been shown recently that DNA repair,
replication and cell cycle are involved in HD. In fact, activation of DNA synthesis and cell
cycle increase apoptosis in terminally differentiated neuronal cells, instead of increasing
cell division [37, 38]. Besides, recent studies have explored the role of DNA repair in
neurodegenerative disease [39] and show that interaction of mHTT with Ku70/ XRCC6
impairs repair activity [40]. A large number of GO terms related to development and
differentiation (57 GO term), transcription process and regulation (31), cell cycle (5), DNA
damage and repair (4), Carbohydrate/Glucose transport/metabolism (4), Cell growth
(7), signaling (31) and others (6) are enriched in module M5. The role of development
and differentiation in HD is not clear. However recent studies in HD [19, 41] indicate
that neurogenesis is possibly altered and differentiation/development could be defective.
Deregulation of transcription is considered to be one of the most important abnormalities
in HD [42]. GO terms related to differentiation are also enriched with proteins in module
M6, although the terms are distinct from that in module M5. All 4 GO terms enriched
in M7 are related to transcription by RNA polymerase III. It is known that both tRNA
and some miRNAs [43] are synthesized by RNA polymerase III, however their role in HD
is unknown. Thus it is evident that the the protein interactions gained in mHTT network
result in enrichment of the biological processes in its modules.
Loss of biological process : The unique GO terms enriched in the modules of wHTT
which are absent in the modules of mHTT network represent the loss of functions due to
mutation in HTT protein. The 5 GO terms inW1 include gene silencing, micro RNA pro-
cessing and translational regulation. The GO terms relating to proteasomal degradation
(1 GO term), cell cycle (1), apoptosis (1) and circadian rhythm (1) are present in W2.
Similarly, signaling (17 GO terms), synaptic transmission, neuronal activities (12) trans-
port (ion/sugar) (5) and others (4) are associated with moduleW3; glucose/carbohydrate
transport and metabolism (5), cell cycle (3) and protein/transmembrane transport (4)
with W6. In W7 only one GO term describing transcription processes and regulation
is enriched. The GO terms and the associated BPs that are lost due to mutation are
9provided in Dataset S4 (sheet 1) and in Supporting Text (Table S3) respectively.
We have clubbed the relevant GO terms to represent signaling, transcription process
and regulation, apoptosis, cell cycle etc. (refer to Table S3 of Supporting Text). For
example, GO terms (GO:0000088) and (GO:0000236, GO:0000087, GO:0007091) which
are enriched in W2 and W6 respectively relates to cell cycle. Similarly the 21 GO terms
which are enriched in M1(4), M3(12), and M5(5) (Dataset S4 (sheet 2)) are also associ-
ated to cell cycle. Although cell cycle is enriched in both wHTT and mHTT modules, no
GO terms are common among them. Thus, the loss of interaction with wHTT may result
in loss of above 4 GO terms in wild type network resulting in LOF, whereas the gain of
interaction with mHTT may be associated with gain of these 21 GO terms relating to
GOF of cell cycle.
It is interesting to note (from Table S3 of Supporting Text) that the GO terms related
to DNA replication, protein folding, autophagy, cell growth are only observed in the
modules of mHTT networks. So these processes are gained due to new interaction with
mHTT. Similarly, GO terms related to gene silencing/ microRNA processing/ translation,
transport (ion/protein/sugar etc) are observed in wHTT network only. Therefore, loss of
interaction with wHTT may result in the loss of these BPs in HD.
Both loss and gain of biological process : Modules in wHTT and mHTT networks have
several proteins or GO terms common among them, which indicate loss as well as gain of
functions and support the notion that both loss and gain may occur due to mutation in
HTT [21]. For example, modules (W1,W5,W7) and (M3,M5,M6) have 17 enriched GO
terms related to transcription processes and regulation. Similarly, modules (W2,W5) and
(M1,M3,M5) share 12 enriched common GO terms related to apoptosis and 4 common
GO terms relating to cell cycle. Thus, the general function of transcription and apoptosis
could arise from loss as well as gain of interactions of mHTT protein. The details of the
functions associated with the 65 GO terms (common between wHTT and mHTT) are
presented in Dataset S4 (sheet 3) and in Supporting Text (Table S3), they correspond to
the gain and loss of functions in the HD.
From the above analysis we observe that most of the functions that are enriched in the
modules of wHTT and mHTT networks are altered in the pathogenesis of HD. The post
transcriptional regulation of genes, associated with module W1 of wHTT network, can be
related to negative regulation of gene expression by the non-coding RNAs like micro RNAs,
which are well documented [44]. Role of apoptosis [5,36], synaptic transmission [45], JNK
pathway [46], transcription deregulation [42], glucose transport [47,48], estrogen [49] and
various types of epigenetic changes including histone modifications in different neurological
diseases [50] in HD pathogenesis have also been reported.
In summary, many new BPs (GO terms) appear in the mHTT network and some of the
BPs present in wHTT network are lost; a few are found to be common between modules
of wHTT and mHTT. As a result some biological functions involving the enriched GO
terms are gained by mHTT and a few are lost from the modules of wHTT. This provides
molecular mechanism of the gain and/or loss of functions observed in HD pathogenesis.
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Mutation in TP53 protein
TP53 protein, initially identified as an oncogene, is now established as a tumor suppressor
gene which participates in diverse cellular functions like transcription regulation, DNA
repair, apoptosis, and genome stability, and many others. Mutation to TP53 is identified
in more than 50% of the tumors. It is evident from COSMIC database [51] that R175H,
R273H and R248W mutations of TP53 are the most prevalent ones. Since TP53 is a
tumor suppressor gene, it is expected that its mutations might result in the LOF of
the wild type protein. Some mutations of TP53 are also known to attain new function(s)
[52,53]. For example, exogenous expression of mutant TP53 (R273H and others) in mouse
cells devoid of endogenous TP53 results in several cellular phenotypes of cancers [54–56].
To understand the underlying molecular mechanism of GOF of mutant TP53, it was
recently shown [57] that nardilysin (NRD1) protein, which does not interact with wild type
TP53 but interacts only with mutant TP53 (R273H), may contribute to the metastatic
properties of this mutant protein.
PPIN of wTP53 and R273H mutant TP53 (mTP53)
In a recent study [57], it has been shown that 17 proteins preferentially interact with the
wild type TP53 (wTP53) and 30 other proteins interact exclusively with mutant TP53
(mTP53). To construct the protein interaction networks we take these primary interacting
proteins of wTP53 and mTP53 and consider their interacting partners existing in BioGrid
database [26]. The detailed protein interaction data are given in the Dataset S5. The
PPIN is constructed separately for wTP53 and mTP53, as described for HTT. It turns
out that wTP53 has 601 secondary interactors whereas mTP53 has only 547. Thus the
PPIN of wTP53 and mTP53 are constructed taking 619 proteins (wTP53+17 primary+
601 secondary) and 578 proteins (mTP53 + 30 primary + 547 secondary) respectively.
Both the networks (shown in Supporting Text (Fig. S2)) are found to be densely packed
with similar structural properties. Their degree distributions are scale free (P (k) ∼ k−γ)
with the exponents γ = 2.04 (wTP53) and 1.89 (mTP53) (Fig. S3 in Supporting Text)
and average degree 〈k〉 = 12.07, 12.29. The other network properties, like the average
clustering coefficient C = 0.452, 0.406, the diameter of the networks D = 4, 4 are also
comparable (listed in Supporting Text (Table S2)).
The change in interactions and the interacting partners due to mutation of TP53 is
shown schematically in Fig. 3(a). Of 17 primary interactors of wTP53, only 5 proteins
remain involved in mutant network as secondary interactors of mTP53 and the remaining
12 do not interact with mTP53. Among the 601 secondary interactors of wTP53, 111
proteins remain as a secondary interactor of mTP53 and 7 of them interact directly, i.e.
7 secondary interactors of wTP53 become primary interactors of mTP53. Lists of these
proteins are given in Supporting Text (Text 1 and Table S1).
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Figure 3. Construction and modularization of wild type and mutant TP53
networks.
(a) Proteins in wTP53 and mTP53 networks : wTP53 (mTP53) protein (red square) has
17 (30) primary and 601 (547) secondary interactors, represented by the inner and outer
circles. Only 5 (7) primary (secondary) proteins of wTP53 interact with mTP53 as
secondary (primary) interactors. Again 111 secondary proteins of wTP53 remain as
secondary interactors of mTP53. (b) and (c) shows the modules of wTP53 and mTP53
network along with few plausible candidate BPs. Details of the GO terms are shown for
wTP53 and mTP53 respectively in Table S6 and Table S7 of the Supporting Text.
Modules of wTP53 and mTP53 networks
In order to identify the modules of the wTP53 and mTP53 networks, we use NGM al-
gorithm [29]. It turns out that PPIN of wTP53 is modularized into 4 modules of size
204, 151, 183 and 81, whereas mTP53 network gives 5 modules of size 193, 127, 25, 111
and 122. The corresponding modularity values are Q = 0.331 and 0.338. Figures 3(b)
and (c) show the modules of wTP53 and mTP53 with different colours. Each module
of wTP53 or mTP53 has unique set of protein. However, there is a large overlap of sec-
ondary interactors (proteins which do not interact directly with TP53) in the wTP53 and
mTP53 networks, which is distributed among different modules (in total 123). We ob-
serve that among 123 common proteins, 34 belong to module W3−M5, whereas module
pairs M1 −W1 (and W4 −M2) have 23 (and 10) common proteins. One can define a
similarity measure σmn using Eq. (1) for every pair of wTP53-mTP53 modules. Taking
the similarity indices σwm as weights (or thickness) of the link we have constructed a
bipartite network which is shown in Fig. 4; the number of proteins is written beside each
of the modules and the number of common proteins is specified along the links.
Enrichment of biological processes for the proteins present in every module of wTP53
and mTP53 PPIN using GeneCodis3 are presented in Dataset S6 and S7 respectively,
where only the GO terms with p < 0.0001 are considered. The number of enriched GO
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terms in modules of wTP53 PPIN are W1(30), W2(17), W3(63), W4(36) and those for
mTP53 are M1(52), M2(71), M4(1), M5(67). Note that module M3 has no GO terms
enriched with p < 0.0001.
Figure 4. Similarity between modules of wTP53 and mTP53 networks. The
bipartite network constructed with the modules of wTP53 and mTP53; the common
proteins present between a pair of wild and mutant module is written on respective link.
The number of proteins that constitute the modules are written beside it.
Loss and Gain of biological processes in TP53 networks
Enrichment analysis of proteins in modules of wTP53 and mTP53 using GeneCodis3
reveals that respectively 127 and 172 GO terms (or biological processes) are enriched
significantly (p < 0.0001). Among 127 GO terms of wTP53 57 GO terms do not appear in
the mTP53 representing loss of the corresponding biological processes. Again the mTP53
network has 102 new GO terms (which were absent in wTP53). Besides, 70 enriched GO
terms are found to be common in modules of mTP53 and wTP53 networks. We further
associate each of the enriched GO terms with a relevent function. Loss and gain of these
broadly classified functions are discussed below.
Gain of biological processes : The biological processes related to 102 new GO terms
of mTP53 are gained due to mutation. The functions enriched in module M1 of mTP53
network are cell-cell communication (no of GO terms 5), signaling (13), protein com-
plex/membrane assembly/stabilization (4), proteasomal degradation (2), cell cycle (3),
DNA damage and repair (1) and others (2). GO terms related to DNA replication (11),
DNA damage and repair (14), cell cycle (4), immunological functions (3), proteasomal
degradation (3) and signaling (1) are enriched in M2. Similarly GO terms related to
differentiation and development (11), signaling (7), transcription (6) , cell proliferation
(4), apoptosis (1), cell cycle (1) and DNA damage (2) and others (4) are enriched with
proteins in module M5. The extensive list of the GOF is given in Dataset S8 (sheet 2)
and in Supporting Text (Table S4). Thus new functions carried out by these biological
processes are due to gain of interaction.
13
Loss of biological processes : On the other hand some of the enriched GO terms of
wTP53 are absent in the mutant network. Corresponding biological processes are lost
due to mutation in TP53. Altogether 57 unique GO terms are enriched with proteins in
modules of wTP53 networks which are classified into broad class of functions (see Dataset
S8 (sheet 1) and Supporting Text (Table S4)). The resulting loss of biological functions
in various modules are, W1 : signaling (8), proteasomal degradation (1), translation (1),
cell migration and movement (2) and others (1); W2 : signaling (4), apoptosis (2) and
immunological (3); W3 : cell cycle (3), signaling (1), transcription process and regula-
tion (13), DNA replication (3), DNA damage and repair (1); W4 : transcription process
and regulation (2), proteasomal degradation (2), translation (5) and others (4); W7 :
transcription process and regulation (1).
Both loss and gain of biological processes : The 70 GO terms common between wTP53
and mTP53 networks are related to the functions, cell cycle (14 GO terms), transcription
(15), DNA damage and repair (10), cell growth (2) and apoptosis (4), signaling (9),
DNA replication (3), proteasomal degradation (3), immunological (2), development and
differentiation (1), metabolism (2) and others (5). Thus these functions are possibly
enriched due to both gain and loss of interactions (details are shown in Dataset S8 (sheet
3) and in Supporting Text (Table S4)).
Analysis of proteins in different modules using tool GeneDecks
Recently metastasis has been shown as the GOF as R273H cells attain metastatic property
in cell model [57]. Since metastasis is not described as a “biological process” in Gene
Ontology term, we have used another tool, GeneDecks [68], which provides a similarity
metric by highlighting shared descriptors between genes, based on annotation within the
GeneCards compendium of human genes (see Text 4 in Supporting Text for details).
Taking the proteins of the modules of wTP53 and mTP53 separately as a query field,
we look for “metastasis” in the attribute “disorder” among many other descriptors which
are enriched for different types of cancers (Dataset S9). It is observed that the descriptor
“metastasis” is enriched with the protein modules W1, W2, W3 of wTP53 network
and all the modules (M1, M2, M3, M4, M5) of mTP53 network. Thus, the loss of
interactions of proteins in the modules W1, W2, W3 of wTP53 due to mutation may
result in the LOFs related to metastasis. Similarly, the gain of interactions of proteins in
all the modules of mTP53 may result in the GOFs related to metastasis.
That LOF of wTP53 and GOF of mTP53 may contribute to invasion and metastasis, is
reviewed recently [69]. TP53 mutations at the DNA binding domain are common and such
mutations suppress expression of target genes. It is supported by several experiments [69]
that suppression of transcriptional program for genes involved in epithelial-mesenchymal
transition (EMT) may contribute to induction of EMT resulting in metastasis. Further,
it is ascertained that loss of functions in wTP53 lead to increased cell motility in vari-
ous cell types, and increased expression of fibronectin, collagens and extracellular matrix
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(ECM) proteins. Enhanced expression of these proteins potentially increase the interac-
tion between cells and ECM. LOF in wTP53 also activate Rho GTPases and modulates
cell migration [69].
Role of mTP53 in metastasis has been established in many other studies. Mutant
TP53 (R175H) is involved in TGF mediated invasion and metastasis in breast cancer
cells through TP63 and SMAD3 [55]. Note that, in our analysis, SMAD is present in
module M5 of mTP53 network. It is known that mutant TP53 (R175H and R273H)
increases endocytic recycling of adhesion molecule integrin and EGFR promoting and
metastasis [56, 70]. Mutation in TP53 also activate EGFR/PI3K/AKT pathways and
thereby increases invasion [71]. Various other mechanisms of increased metastasis by the
mutant TP53 have also been studied [69]. Thus the gain of biological processes obtained
from the analysis of mTP53 protein networks provides an explanation of GOFs observed
in cancers.
Robustness analysis
In general, the modularization methods partition the network into communities of proteins
which are densely connected. Thus in a large network it is quite expected that deletion
of small fraction of links, whether selected methodically or randomly, does not alter the
overall structure significantly. In fact, the degree distributions of all four networks studied
here (namely PPIN of wHTT, mHTT, wTP53 and mTP53) are scale free (see Fig. S3
of Supporting Text), and it is known that such scale free networks are robust against
random removal of nodes or links, but they could be fragile against targeted attack [72].
Table 1. Change in the total number of proteins and the interactions after excluding
(a) genetic interactions and then (b) excluding interactions which are validated by only
one Y2H experiment.
Total no.
of interac-
tions
(a)Excluding
genetic(%)
(b)Excluding
genetic &
Y2H(%)
Total
no. of
proteins
Excluding
genetic &
Y2H(%)
PPIN(human) 59027 58927(99.84%) 47244(80.04%) 12515 11630(9.29%)
wHTT 1380 1375(99.64%) 1231(89.20%) 306 292(9.54%)
mHTT 13105 13058(99.64%) 11478(87.58%) 1542 1486(9.64%)
wTP53 3718 3716(99.95%) 3205(86.20%) 619 590(9.53%)
mTP53 3521 3515(99.83%) 3136(89.07%) 578 551(9.53%)
Again, since several databases of protein interactions largely overlap [73] in their con-
tents, it is natural to expect that the broadly classified biological functions obtained here
for HTT and TP53 networks would not differ substantially. In this study we used Bi-
ogrid [26] for creating the differential PPIN of the wild type and mutant HTT and TP53
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Table 2. Comparison of number of proteins and GO terms in the modules of mHTT
with respective of ‘most similar module’ of the network (a) after excluding genetic and
Y2H experiments and (b) after deletion of 10% links.
mHTT Module (a) Excluding
genetic &
Y2H
(b) Random dele-
tion of 10% links
MSM Common (%) MSM Common (%)
M1
No. of Proteins : 643 656 542 (84.29%) 612 521 (81.03%)
No. of GO terms : 161 161 147 (91.30%) 163 147 (91.30%)
M3
No. of Proteins : 377 287 211 (55.97%) 309 209 (55.44%)
No. of GO terms : 78 95 64 (82.05%) 80 59 (75.64%)
M5
No. of Proteins : 485 442 423 (87.22%) 424 397 (81.86%)
No. of GO terms : 198 186 173 (87.37%) 174 162 (81.82%)
M6
No. of Proteins : 7 5 5 (71.43%) 5 5 (71.43%)
No. of GO terms : 12 16 11 (91.67%) 16 11 (91.67%)
M7
No. of Proteins : 22 7 7 (31.82%) 612 7 (31.82%)
No. of GO terms : 5 8 5 (100.0%) 7 4 (80.00%)
proteins by connecting every pair of proteins which are listed in BioGrid as interact-
ing partner of each other. This includes experimentally validated genetic and physical
interactions. To check the robustness of our analysis, first let us remove all genetic in-
teractions listed in BioGrid. This reduces the total number of protein interactions of
BioGrid to 99.84%, whereas the interactions of wHTT, mHTT, wTP53 and mTP53 are
reduced to 99.64%, 99.64%, 99.95% and 99.83% respectively (see Table 1). Among the
other experiments considered in BioGrid, Yeast 2 Hybrid (Y2H) assay results in larger
false positives [74]. Thus we further remove all the interactions which are identified only
once by Y2H. This stringent criterion consequently reduces both the number of interac-
tions and the number of proteins by ∼ 10%. The total number of interactions of BioGrid
is, however, reduced by 20%. Since the wild type and mutant networks are altered only a
little compared to the expected value 20%, one expects that deletion of a small fraction
of interactions will not change the network properties significantly.
To demonstrate this explicitly, we reconstruct the PPIN of mHTT keeping only the
reduced set of interactions and then identify the protein modules using Newman Girvan
algorithm. The enriched GO terms (p < 0.0001) from GeneCodis3 shows that every
module of mHTT (M1, M3, M5, M6 and M7) has significant protein overlap with only
‘one distinct module’ of the reduced network, which is referred to as the ‘most similar
module’ (MSM) henceforth. The number of overlapping proteins and GO terms between
the modules of mHTT and their corresponding MSM in the reduced network are listed in
Table 2. Evidently, in all cases, about 90% of the GO terms are retained. Thus, the loss,
gain and loss/gain of biological processes obtained from BioGrid are quite robust.
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For completeness, we also removed randomly 10% links of mHTT network and repeat
the above analysis which is summarized in Table 2. Again, we find that about 90% of the
GO terms enriched in this network are identical to those obtained for mHTT. Thus, in
general, the enriched biological processes obtained through this analysis are quite robust.
Discussion and Conclusion
Mutation in protein may change its preference for binding with other proteins and alter the
corresponding PPIN substantially. We use a graph theory based modularization approach
to identify the modules of PPINs, and provide a comparative study of these differential
networks using two examples; one for HD and another for cancers. The general philosophy
of this analysis is depicted schematically in Fig. 5. In this figure, the wild type protein
interacts with many other proteins forming a complex interaction network. Broadly, the
schematic wild type network has three subgraphs or modules (A, B and C); proteins in
each module are marked there with identical colours. The mutant protein loses some
proteins as interacting partners (marked as pink) and gains some new ones (marked as
orange, blue and violet). The network of the mutated protein has a revised modular
structure A′, B′ and D. Module A′ and B′ are re-structured and they have some proteins
from other modules and some new proteins. Module D is gained by the mutation as most
of proteins in this module were not present in the wild type network, and module C is
lost. Correspondingly, the biological processes (GO terms) which are enriched in module
D are gained and those enriched in module C are lost. We argue that this loss or gain of
BPs lead to loss or gain of functions in the pathogenesis of the mutation induced disease.
In this article we explained the general idea of ‘obtaining the loss and gain of functions
from the loss and gain of BPs enriched in protein modules’ using two examples; one for
HD and another for cancers. Our analysis predict a set of broadly classified biological
processes (from the the GO terms enriched in the modules of HTT and TP53 networks)
which could be involved in the pathogenesis of HD and cancers respectively. In HD, the
broadly classified BPs, like post transcriptional regulation of genes, apoptosis, synaptic
transmission, JNK pathway, transcription deregulation, glucose transport, histone mod-
ifications etc are enriched with the proteins in modules of wHTT and mHTT networks.
These BPs are already known to be altered in HD pathogenesis. Similarly, the gain and
loss of BPs mTP53 results in the metastatic properties, which have been observed recently.
Although, we demonstrated the plausible loss and gain of biological processes in two
examples where mutation alters protein interaction networks of wild type protein, the
methodology discussed here can be adopted and applied to study differential PPIN in
general. In particular, knowing the changes in the protein interaction network, either due
to mutations that modify the structure of the protein at the binding surface or due to
the change in interaction environments, one can predict what alteration might occur in
the biological processes and functions. Such analysis may help understanding the loss or
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gain of biological processes/functions in genetic diseases caused by mutations. This may
in future lead to better design of disease intervention through targeting the biological
processes/functions of specific modules.
Figure 5. Loss and gain of functions from differential network studies. The
general philosophy of the current work is described here for a schematic protein
interaction network, where the wild type and the mutant protein have 52 and 54
interactors respectively. There are three modules in wild type network (A, B, and C);
all proteins in a given module are marked with same colour. After mutation the protein
looses some interactors (marked as pink) and gain some new ones (marked as orange,
blue and violet). The PPIN of mutant protein has three modules A′, B′ and D. Module
A′, which primarily contains proteins of module A, has some proteins from module B
(green) and some new proteins (violet). Most of the proteins in module D are new
interactors and thus this module is gained by the mutation. Similarly proteins of
module C have lost their interactions. Correspondingly, the BPs which are enriched in
module D are gained and those enriched in module C are lost. This loss or gain of BPs
lead to loss or gain of functions in the pathogenesis of the mutation causing disease.
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Text 1 : Differential interaction due to mutation of
HTT and TP53
Huntingtin protein
The mutated huntingtin protein mHTT preferentially interact with a set of different pro-
teins compared to the wild type HTT (wHTT). The data for this differential interactions
are curated from literature as follows. Primarily we have collected 328 HTT-interacting
proteins identified by yeast 2 hybrid (Y2H) assays [1–3], affinity pull down followed by
mass spectrometry assay [3] and proteins in the aggregates of mutant HTT [4]. Since
Y2H assay results in false positives [5], we consider only 154 HTT interacting proteins
that are validated by (i) second method like co-immunoprecipitation or (ii) the interacting
proteins are tested for their implications in HD pathogenesis in cell or animal models of
HD. Out of these sorted 154 HTT interacting proteins 17 proteins are seen to interact
with wHTT, 12 proteins are identified in the aggregates of mutant HTT and 25 proteins
interact preferentially with mutant HTT. Thus in totality, wHTT interact with 17 pro-
teins whereas mHTT interacts with completely new 37 proteins. The list of these protein
along with other subsidiary informations are presented in Dataset S1 (sheet 1).
The PPIN of wHTT is constructed by taking 306 proteins (wHTT, its 17 primary and
288 secondary interactors) and interactions among them, whereas the PPIN of mHTT
has 1542 proteins (see Dataset S1 (sheet 2 and sheet 3)). Corresponding networks, drawn
using Cytoscape [6], are shown in Fig. S1.
Common proteins in wHTT and mHTT networks
Out of the 17 primary interactors of wHTT, 8 proteins namely (DLG4, CASP3, CTBP1,
EIF2C2, REST, ZDHHC17, MEF2D, HIP1) change their direct interaction with wHTT
and get involved in mHTT PPIN as secondary interactors. Whereas out of 288 secondary
interactors in wHTT PPIN, 10 proteins now directly interact with mHTT. The list of these
proteins are (PARK2, CASP10, TP53, CREBBP, SIN3A, CASP2, NFYC, CASP8, SP1,
TBP). Also it is to be noted that, there are 107 proteins remain as secondary interactors
2Figure S1. The interactome of wHTT and mHTT involves 306 and 1542 proteins
respectively. If a pair of proteins present in a particular set has interaction between
them, then a link is constructed between these two proteins(nodes). Exhausting every
pair of proteins for both the sets we end up in constructing the interactome of the
wHTT (left) and mHTT (right) using Cytoscape software [6].
in both the wHTT and mHTT PPIN (list given in Table S1).
TP53 protein
TP53 is a tumor suppressor gene. The mutation of this gene causes cancer. In a recent
work Coffill et. al. [7] have studied the biological effects resulting from the missense
mutations in TP53 (p53R273H). Their experimental results indicate that wTP53 and
mTP53 differentially interact with 17 and 30 proteins; list of these proteins are given
Dataset S5 (sheet 1).
The PPIN of wTP53 is constructed by taking 619 proteins (wTP53, its 17 primary and
601 secondary interactors) and interactions among them, whereas the PPIN of mTP53
has 578 proteins (see Dataset S5 (sheet 2 and sheet 3)). The corresponding networks,
drawn using Cytoscape [6], are shown in Fig. S2.
Figure S2. The PPIN of wTP53 and mTP53 interacting proteins are constructed using
the Cytoscape software [6]. The network in the left is for the wild TP53 and in right is
for mutant TP53.
3Common proteins in wTP53 and mTP53 networks
Similar to the previous case the mutation of TP53 causes change in interacting partners
of TP53, altogether resulting in different secondary interactors. Wild TP53 primarily
interact with 17 proteins, among them 5 proteins (YWHAG, BAG6, TUBB3, RPL5,
MDM2) lose their interaction with wTP53 and get involved in mTP53 PPIN as secondary
interactor. Again these 7 proteins (PARD3, PLK1, KHDRBS1, CSNK2A1, PSMD2,
CSNK2B, PSMC1) which were secondary interactors in wTP53 PPIN now interact with
mTP53 directly. Apart from these there are 111 proteins common to both wild and
mutant TP53 network, and are secondary interactors for both the networks (listed in
Table S1).
Text 2 : Analysis of network structure
In recent years theory of complex networks has been used enormously in various fields
[8]. The social systems (friendship, mobile or citation networks), information systems
(World Wide Web and router networks), biological systems (neural, protein folding and
gene regulatory networks) are a few to mention. Network theory provides a quantifiable
description for comparison and characterization of complex networks. Here we shall focus
on some robust measures of network topology : the degree distribution, the clustering
coefficient, the average path length and the diameter.
Degree Distribution: The most elementary characteristic of a node (vertex) is its
degree. The degree of a vertex k in a network is defined as the number of edges connected
to that vertex. The degree distribution, P (k), gives the probability that a selected node
has exactly k links. P (k) is obtained by counting the number of nodes with k = 1, 2, . . .
links and then normalizing by the number of nodes N. The degree distribution of many
real world networks, including PPINs [9] are commonly scale free, i.e.
P (k) ∼ k−γ .
The degree distribution P (k) for all four PPINs, i.e. wild and mutant networks of
HTT and TP53, are found to be scale free (see Fig. S3), with the exponent γ ≃ 2. The
average degree and our best estimate of the exponent γ are listed in Table S2.
Clustering coefficient: In a highly dense network, the neighbours of a given node
are very likely to be connected among themselves. The clustering coefficient
ci =
2Ei
ki(ki − 1)
gives a measure of how connected are the neighbours of node i. Here Ei the actual number
of links which connects all the ki neighbours of node i and ki(ki − 1)/2 is the maximum
4number of possible links. Clearly the maximum value of ci is unity. The average clustering
coefficient of a network of N nodes is
C =
1
N
N∑
i
ci,
which gives a notion of how dense is the network, with maximum value 1 corresponding
to a clique (i.e. all N nodes are connected to each other).
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Figure S3. Degree distribution of wild and mutant HTT and TP53 network. All the
four network follows scale free degree distribution. The corresponding power-law
exponent is written in the graph itself.
Average path length : In a connected network, a given node i can be reached from
any other node j by several alternative paths. The shortest path l(i, j) is the path with
the smallest number of links between nodes i and j. The average path length of a network
of N nodes, thus N(N − 1)/2 vertex pairs, is
L =
∑N
i 6=i 2l(i, j)
N(N − 1)
.
The network diameter : The network diameter D is the largest of the shortest
paths among all the vertex pairs. In other words, D is the length of the ‘longest’ shortest
path in the network. The average path length and diameter for the networks of wHTT ,
mHTT, wTP53 and mTP53 are calculated and their values are listed in the Table S2.
Modular structure of network : Other than these network parameters, detection
of modules or community structures is widely used to reveal the organizational principles
of nodes within the context of the entire system. Modules are specific groups of nodes
which has larger density of links within the group than outside it. Each of such modules
5can be regarded as a discrete entity whose function or properties are in some way separable
from other modules. A large variety of community detection techniques [10] have been
developed based on centrality measures, link density, percolation theory etc.
The most obvious way of finding groups in a network is to minimize the number
of edges connecting the groups. Recently, Newman et.al. [11] proposed a method of
finding community structure of a network by associating a score called modularity Q for
each possible partition of a network; a good partition of a network can be obtained by
maximizing Q. It is argued that simply rearranging the network, such that only few edges
exist between the communities, is not enough. Rather one must rearrange it in a way that
the communities are connected with fewer than expected edges. Based on this, Newman
et. al. defined a score called modularity Q which is proportional to the number of edges
present within the groups minus the expected number in an equivalent random network.
To be more precise, let us consider an undirected network of N nodes labeled by
i = 1, . . .N, having an adjacency matrix A with boolean elements,
Aij =
{
1, if nodes i and j are connected
0, otherwise.
Thus, the degree of the node i is ki =
∑
j Aij , and the total number of links m =
1
2
∑
i ki
= 1
2
∑
ij Ai,j . If the network is to be partitioned into groups, the modularity is defined
by
Q =
1
2m
∑
ij
(
Aij −
kikj
2m
)
κi,j , (1)
where κi,j = 1 (or 0) if nodes i and j belong to same (different) partitions. Note that
kikj/2m is the expected number of links between nodes i and j, if edges were placed at
random and it assures that Q is maximum when two groups are connected by smaller
than expected number of links. A positive values of Q indicates the possible presence of
community structure(s) and one need to look for a partition for which the modularity is
preferably large and positive. In the following we apply this procedure to obtain modular
structure of wHTT, mHTT, wTP53 and mTP53 networks.
Modularizing the wHTT and mHTT network we see that wHTT network contains 7
and mHTT network contains 8 modules. Also the wTP53 and mTP53 networks divides
into 4 and 5 modules. The size of each modules i.e. number proteins present in each
modules are given in the Table S2. The names of the proteins that constitute the modules
of wild and mutant HTT network are provided in the Dataset S2 (sheet 1) and S3 (sheet
1) respectively. Similarly for TP53, the name of the proteins present in the modules of
the wild and mutant TP53 networks are given in the Dataset S6 (sheet 1) and S7 (sheet
1) respectively.
6Text 3 : Enriched biological processes in modules
To find the possible function(s) of the modules, we utilized bioinformatics enrichment
tools. There are many tools available for such enrichment analysis, we mainly used
GeneCodis3 [12] for the convenience.
GeneCodis is a web-based tool for interpretation of large scale data integrating from
different sources like Gene Ontology (GO, pathways in Kyoto Encyclopedia of Genes
and Genomes (KEGG), PANTHER pathways, Online Mendelian inheritance in Man and
others). Given a set of genes in the query field, GeneCodis associates GO terms for each
gene and calculate whether the fraction of genes in a particular GO term among the input
gene list is over represented compared to the background frequency (the total number of
genes involved in that GO term over the total number gene in the organism). It further
corrects the significance level for multiple testing. When the list of proteins present in a
given module is feed to GeneCodis3 as the query set, it gives a list of associated biological
processes (GO terms) and their respective significance values. In this study we considered
only those GO terms which have p < 0.0001.
HTT PPIN : The set of proteins present in each of the 7 and 8 modules of wHTT
and mHTT PPINs are analyzed with GeneCodis3. The GO terms associated with each
of the modules are enlisted in Dataset S2 and S3 according to high to low signifi-
cance. The GO terms with corrected significance value greater than 0.0001 are discarded.
Thus the number of GO terms belonging to each of the modules of wHTT PPIN are
W1(7), W2(24), W3(47), W4(7), W5(32), W6(13), W7(3) and for mHTT PPIN are
M1(161), M3(78), M5(198), M6(12), M7(5). For the modulesM2, M4 andM8, all the
GO terms that are obtained after GeneCodis analysis have p-value greater than 0.0001,
so these GO terms are not considered for further analysis. Accumulating all the GO
terms involved in the modules of wHTT and mHTT PPIN, one gets 129 and 389 GO
terms respectively. (Note that merely adding the number of GO terms for each modules
separately for wHTT and mHTT networks gives numbers greater than that mentioned;
reason for this is that a single GO term can occur simultaneously in two or more modules
of wHTT or mHTT network.) A detailed study reveals that both these set of GO terms
obtained for wHTT and mHTT modules has 65 GO terms in common. Thus one can
conclude that the unique GO terms that are involved only in wHTT and mHTT network
are 64(= 129−65) and 324(= 389−65). The Biological processes relating to these 64 GO
terms in wHTT network are lost due to mutation-LOF, whereas the BPs corresponding
to 324 GO terms are GOF, and BPs for the common ones 65 are GOF/LOF both. We
group the similar GO terms under a single broad BP. A clear data demonstrating these
LOF, GOF and GOF/LOF (see Table S3) is given Dataset S4.
TP53 PPIN : A similar study for the module of wild and mutant TP53 PPIN modules
is being done to obtain the LOF, GOF and GOF/LOF separately. The total number of
GO terms (considering GO terms with p < 0.0001 for all the modules of wTP53 and
mTP53 separately) that are present for wild and mutant TP53 networks are 127 and 172
7respectively. These two sets has 70 GO terms in common. Thus the unique GO terms
present for the wild and mutant TP53 are 57 and 102; these are responsible for LOF and
GOF function respectively. For the details of the loss and gain of functions refer to Table
S4 and Dataset S8.
Text 4 : Enrichment of metastasis from GeneDeck
Metastasis, which is shown as GOF in mutation of TP53 [7], is not described for “biolog-
ical process” in Gene Ontology term. We have used another tool, GeneDecks [13], which
provides a similarity metric by highlighting shared descriptors between genes, based on
annotation within the GeneCards compendium of human genes. Given a set of genes as
query to the field Set Distiller in GeneDecks (Version 3), an online analysis tool that pro-
vides output of various descriptors like various cancers and diseases with the attribute Dis-
order taking data from different resources like Alma Knowledge Server, PharmGKB, The
Breast Cancer Gene Database, Tumor Gene Database, GeneTests (formerly GeneClin-
ics), OMIM, Swiss-Prot and Genatlas. The proteins present in the modules of wTP53
and mTP53 are analyzed using GeneDeck in order to get the information about the pres-
ence of metastasis in the corresponding modules. It is seen that the almost all the modules
of wTP53 (except module W4) and mTP53 shows enriched metastasis (refer to Dataset
S9 ).
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9Table S1. List of the secondary interacting proteins that are common in to both wild
and mutant PPIN of HTT and TP53 separately.
Common Protein name
wHTT-mHTT(107) YWHAQ, NFATC2, BCL3, HIST3H3, SMARCA4, TBK1, MAPK1, BTRC, SMARCC2,
APC, PRKCA, CTTN, SMARCE1, UBC, MEN1, WAS, TCF7L2, KDM1A, NEU-
ROD1, CASP6, RBBP5, GTF2E2, CBL, ZEB1, NUP98, AKT1, NUB1, IFT57, DHX58,
BLM, TUBG1, EHMT1, COPS5, EHMT2, KDM5C, MAPK14, PSMC3, CFLAR,
CARM1, NCOR1, CASK, MDM2, PRMT5, NCOA3, HSPB1, CDC42, BRCA1, HTR2C,
HSPD1, FZD7, TBL1X, UBE2I, SENP3, HDAC1, HDAC2, HEY2, HDAC3, HDAC4,
SUB1, SREBF2, HDAC5, TP73, THAP11, EP300, BID, HDAC9, TCF4, GTF2B,
WIPF1, EGFR, KAT2A, SNCA, KAT2B, MLL, PFDN1, GRIK5, SERPINH1, RPS10,
DNM1, SUMO1, SUMO2, USO1, KAT8, CHD3, RAC1, SIN3B, IKZF1, HIC1, DBNL,
GRIN2B, IKZF4, SOX2, EIF6, YWHAE, DICER1, MAP3K14, BIRC2, MECOM, TGIF1,
KHDRBS1, BIRC5, CABIN1, SATB1, HGS, ABL1, BCL2, XIAP
wTP53-mTP53(111) UBC, TANK, RBBP4, RBBP7, PPP4C, MAGED1, SETDB1, SMAD1, UIMC1, CDH1,
TERF1, NOLC1, PSMD10, CCDC85B, UBE2I, USP42, IKBKB, WRAP73, DCAF7,
E2F1, MGMT, NCL, HSP90AA1, PRMT1, SRRM1, SRRM2, CHEK2, FBXW11, ITCH,
PIK3R1, RB1, KIF5C, YWHAZ, STUB1, ARRB1, EP300, AR, SNAI1, RPS6KB1,
MAP3K5, ESR1, UCHL1, UCHL5, STAU1, PCK1, MDM4, RPA1, RPA2, RPAP1,
BCL3, CDC5L, RASSF8, HSPA1A, PSMA3, NCOR2, PSMA7, TP53BP1, NDRG1,
EXO1, CASP8, ARAF, H2AFX, PRPF40A, PELP1, EIF2C3, PIN1, NR3C1, CLSPN,
RAD21, NEDD4, NEDD8, IMMT, CHAF1A, TSC1, MTA1, PUF60, CTBP1, MLLT4,
MAPK6, TNFRSF1A, MEPCE, ARR3, SRGAP2, CREBBP, SRC, PRKCZ, SFN, CDK9,
ATM, WNK1, RIPK1, SUMO1, SUMO2, HDGF, BTRC, LRIF1, CDKN1A, MDC1,
RNPS1, PPP2R2D, HIST1H3A, HDAC1, HDAC3, DISC1, HDAC5, HDAC6, TP73,
TAF1, PSMC4, PSMC5, C5ORF25
Table S2. Comparison of network properties between wild-type and mutant PPIN of
HTT and TP53.
network node edge 1 〈k〉 γ C d L No. of Modules: Module sizes Q
wHTT 306 1380+17 9.13 1.95 0.436 4 2.418 7: 18, 66, 79, 18, 82, 8, 35 0.415
mHTT 1542 13105+37 17.05 1.99 0.361 4 2.349 8: 643, 3, 377, 2, 485, 7, 22, 3 0.302
wTP53 619 3718+17 12.07 2.04 0.452 4 2.232 4: 204, 151, 183, 81 0.331
mTP53 578 3521+30 12.29 1.89 0.406 4 2.282 5: 193, 127, 25, 111, 122 0.338
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Table S3. LOF, GOF, LOF/GOF occurred due to mutation of HTT.
GO terms related to Modules of mHTT network Modules of wHTT network Modules of wHTT-mHTT network
(unique GO terms) (unique GO terms) (unique GO terms)
Cell cycle M1(4),M3(12),M5(5) W2(1),W6(3) (W2,W5)-(M1,M3,M5)(4)
Signaling M1(30),M5(31),M6(2) W3(17),W4(4) (W3,W4,W5,W7)-(M1,M5)(9)
Transcription processes and regula-
tion
M1(5), M3(5), M5(31) W7(1) (W1,W5,W7)-(M3,M5,M6(17)
Apoptosis M1(11) W2(1) (W2,W5)-(M1,M3,M5)(12)
DNA replication M3(12) - -
DNA damage and repair M1(6),M3(17),M5(4) - (W3,W5)-(M1,M3,M5)(4)
Immunological M1(7) - -
Protein folding M1(7) - -
Autophagy M1(5) - -
Translation M1(3) - -
Metabolism M1(1) - -
Development and differentiation M1(4),M5(57),M6(8) - (W3,W5)-M5(5)
Cell migration and shape M1(4) - -
Proteasomal degradation M1(14) W2(1) (W2,W5)-(M1,M3)(3)
Carbohydrate/Glucose trans-
port/metabolism
M5(4) W6(5) -
Protein complex/membrane assem-
bly/stabilization
M1(9) - -
Cell growth M5(7) - -
Transcription from RNA polymerase
III
M7(4) - -
Others M1(4),M3(5),M5(6) W3(4) (W2,W3,W4,W5,W6)-(M1,M5)(6)
Gene silencing/micro RNA and
RNA processing /translation
- W1(5) -
Synaptic transmission and neuronal
activity
- W3(12) W3-M1(2)
Transport (ion/sugar) - W3(5) -
Circadian rhythm - W2(1) -
Protein /transmembrane transport - W6(4) -
NFKB1 regulation - - W2-M1(2)
Proliferation/growth - - W5-(M1,M3,M5)(1)
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Table S4. LOF, GOF, LOF/GOF occurred due to mutation of TP53.
GO terms related to Modules of mTP53 network Modules of wTP53 network Modules of wTP53-mTP53 network
(unique GO terms) (unique GO terms) (unique GO terms)
Cell cycle M1(3),M2(4),M5(1) W3(3) (W1,W3,W4)-(M1,M2,M5) (14)
Signaling M1(13), M5(7), M2(1) W1(8), W3(1), W2(4) (W1,W2,W3)-(M1,M4,M5) (9)
Transcription processes and
regulation
M5(6) W3(13), W4(2), W7(1) (W1,W2,W3,W4)-(M1,M2,M5) (15)
Apoptosis M5(1) W2(2) (W1,W2,W3,W4)-(M1,M2,M5) (4)
DNA replication M2(11) W3(3) W3-(M2,M5) (3)
DNA damage and repair M1(1), M2(14), M5(2) W3(1) (W1,W2,W3,W4)-(M1,M2,M5) (10)
Immunological M2(3) W2(3) (W2,W4)-(M1.M2) (2)
Development and differenti-
ation
M5(11) - W3-M5 (1)
Proteasomal degradation M1(2),M2(3) W1(1), W4(2) (W4)-(M1.M2) (3)
Cell-cell communication M1(5) - -
Cell proliferation/growth M5(4) - W3-M5 (2)
Protein complex/membrane
assembly/stabilization
M1(4) - -
Others M1(2), M5(4) W1(1), W4(4) (W1,W2,W3,W4)-(M1,M2,M5) (5)
Translation - W1(1), W4(5) -
Cell Migration and move-
ment
- W1(2) -
Circadian rhythm - W4(1) -
Metabolism - - W4-M2 (2)
